Pharmacoeconomics

Economics is the language of scarcity and choice. Two challenges identified in expanding access to antiretroviral therapy in Africa are scarcity of finance and scarcity of trained healthcare professionals. Economic evaluation provides the tools to help choose between different strategies and therefore identify how best these scarce
resources can be used to achieve the best value i.e. maximise the number of HIV infected individuals who can access treatment.

This program of work is conducted by staff and associates of Realta with project based funding.

Ongoing projects

1. Evaluation of the capacity, feasibility and cost of a public private partnership which involves private clinicians treating public patients in Botswana. This study is a collaboration with the Ministry of Health in Botswana, World Health Organisation and African Comprehensive HIV/AIDS Partnership (ACHAP).
2. Economic evaluation of strategies to decrease mother to child transmission of HIV during breastfeeding. This study is a collaboration with Lilongwe Hospital in Malawi, Centre for Disease Control, Atlanta and the University of North Carolina.
3. Economic evaluation of antibiotic preventative therapy in HIV infected children in Zambia. This study is a collaboration with University teaching Hospital, Lusaka and Medical Research Council, UK.
4. Cost of providing comprehensive HIV care including antiretroviral therapy at four African sites. This study is a collaboration with Joint Clinical Research Centre in Uganda, Kenyatta Hospital in Kenya, CHU de Treichville in Cote d’Ivoire and CHU FANN in Senegal and Pharmaccess International.

Back